177 related articles for article (PubMed ID: 19400598)
1. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study.
Merat S; Rezvan H; Nouraie M; Jamali A; Assari S; Abolghasemi H; Radmard AR; Zaer-Rezaii H; Zeid-Abadi-Nejhad M; Hosseini MR; Amini-Kafiabad S; Maghsudlu M; Pourshams A; Malekzadeh R
Arch Iran Med; 2009 May; 12(3):225-31. PubMed ID: 19400598
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
Amini S; Mahmoodi MF; Andalibi S; Solati AA
J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
[TBL] [Abstract][Full Text] [Related]
3. Re: The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study.
Nasseri-Moghaddam S
Arch Iran Med; 2009 Jul; 12(4):437; author reply 437-8. PubMed ID: 19566369
[No Abstract] [Full Text] [Related]
4. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size.
Luo Z; Xie Y; Deng M; Zhou X; Ruan B
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):695-700. PubMed ID: 21617533
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiology of hepatitis B virus infection among children in Mongolia: results of a nationwide survey.
Davaalkham D; Ojima T; Nymadawa P; Tsend N; Lkhagvasuren T; Wiersma S; Uehara R; Watanabe M; Oki I; Nakamura Y
Pediatr Int; 2007 Jun; 49(3):368-74. PubMed ID: 17532838
[TBL] [Abstract][Full Text] [Related]
6. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
Sofian M; Aghakhani A; Izadi N; Banifazl M; Kalantar E; Eslamifar A; Ramezani A
Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study.
Merat S; Rezvan H; Nouraie M; Abolghasemi H; Jamali R; Amini-Kafiabad S; Maghsudlu M; Pourshams A; Malekzadeh R
Arch Iran Med; 2010 Mar; 13(2):99-104. PubMed ID: 20187662
[TBL] [Abstract][Full Text] [Related]
8. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran.
Roshandel G; Semnani S; Abdolahi N; Besharat S; Keshtkar AA; Joshaqani H; Moradi A; Kalavi K; Jabbari A; Kabir MJ; Hosseini SA; Sedaqat SM; Danesh A; Roshandel D; Hedayat-Mofidi SM
J Microbiol Immunol Infect; 2008 Jun; 41(3):227-30. PubMed ID: 18629418
[TBL] [Abstract][Full Text] [Related]
10. A population based survey of hepatitis B virus infection in a southern Italian town.
Stroffolini T; Guadagnino V; Chionne P; Procopio B; Mazzuca EG; Quintieri F; Scerbo P; Giancotti A; Nisticò S; Focà A; Tosti ME; Rapicetta M
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):415-8. PubMed ID: 9494849
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran.
Alizadeh AH; Ranjbar M; Ansari S; MirArab A; Alavian SM; Mohammad K; Adibi P; Sadri GH; Keramat F; Ardalan A; Arabi M; Gharekhani S; Ataei A; Amraei GR; Hosseinzadeh M; Hatami S; Zali M
East Mediterr Health J; 2006 Sep; 12(5):528-37. PubMed ID: 17333790
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of markers of hepatitis B virus infection among the general population of the municipality of Slavonski Brod.
Jelić O; Jelić D; Balen I; Jelić A; Jelić N; Mihaljević I
Acta Med Croatica; 1994; 48(3):111-6. PubMed ID: 7532046
[TBL] [Abstract][Full Text] [Related]
13. Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B virus in Iran.
Abedi F; Madani H; Asadi A; Nejatizadeh A
Arch Virol; 2011 Apr; 156(4):629-35. PubMed ID: 21229276
[TBL] [Abstract][Full Text] [Related]
14. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
15. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
[TBL] [Abstract][Full Text] [Related]
16. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
17. Exposure to hepatitis B virus in the general population of Hisayama, Japan: significance of isolated antibody to hepatitis B surface antigen in general population.
Kajiwara E; Akagi K; Ueda K; Murai K; Hasuo Y; Kiyohara Y; Wada J; Kawano H; Kato I; Fujishima M
Fukuoka Igaku Zasshi; 1992 Jun; 83(6):250-6. PubMed ID: 1511950
[TBL] [Abstract][Full Text] [Related]
18. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population.
Fabris P; Baldo V; Baldovin T; Bellotto E; Rassu M; Trivello R; Tramarin A; Tositti G; Floreani A
J Clin Gastroenterol; 2008; 42(5):527-32. PubMed ID: 18277889
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of hepatitis B virus in Iran.
Mohebbi SR; Amini-Bavil-Olyaee S; Zali N; Noorinayer B; Derakhshan F; Chiani M; Rostami Nejad M; Antikchi MH; Sabahi F; Zali MR
Clin Microbiol Infect; 2008 Sep; 14(9):858-66. PubMed ID: 18844687
[TBL] [Abstract][Full Text] [Related]
20. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
